Property-based optimisation of PROTACs
RSC Medicinal Chemistry · 2025 · 16 (2) · 449-456
DOI: 10.1039/d4md00769g ↗Kurz gefasst
Editorial in der Zeitschrift RSC Medicinal Chemistry, 2025. Verfasst von James S Scott und 2 weiteren Autor:innen. Beteiligte Einrichtung: Oncology R&D, AstraZeneca 1 Francis Crick Avenue Cambridge CB2 0AA UK jamie.scott@astrazeneca.com. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
PROTACs are an emerging therapeutic approach towards targeted protein degradation. This article examines the leading examples of this modality that are in clinical development through the prism of their physicochemical properties.
Autor:innen und Institutionen
- Oncology R&D, AstraZeneca 1 Francis Crick Avenue Cambridge CB2 0AA UK jamie.scott@astrazeneca.com.
- Discovery Sciences, AstraZeneca 1 Francis Crick Avenue Cambridge CB2 0AA UK.
ORCID-Profile: James S Scott, Iacovos N Michaelides, Markus Schade
Zitieren
APA
Scott, J. S., Michaelides, I. N., & Schade, M. (2025). Property-based optimisation of PROTACs. RSC Medicinal Chemistry, 16(2), 449-456. https://doi.org/10.1039/d4md00769g
Vancouver
Scott JS, Michaelides IN, Schade M. Property-based optimisation of PROTACs. RSC Medicinal Chemistry. 2025;16(2):449-456. doi:10.1039/d4md00769g
BibTeX
@article{Scott2025,
author = {Scott, James S and Michaelides, Iacovos N and Schade, Markus},
title = {Property-based optimisation of PROTACs},
journal = {RSC Medicinal Chemistry},
year = {2025},
volume = {16},
number = {2},
pages = {449--456},
doi = {10.1039/d4md00769g}
}
EUVIMED